News
Tharimmune soared over 42% after hours Wednesday after reporting strong data for its opioid overdose prevention drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback